Entrada Therapeutics Inc Asset Turnover Ratio (TRDA), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Entrada Therapeutics Inc   (NASDAQ: TRDA)
 

Entrada Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Entrada Therapeutics Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.01 in the third quarter (Sep 30 2026)

Within sector 193 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2026, to 3855, from total ranking in the second quarter 2026 at 4003.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TRDA Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change -35.36 % -33.4 % -31.03 % -16.69 % -13.82 %
Y / Y Revenue Change -43.93 % -53.95 % -95.74 % -96.53 % -91.75 %
Asset Turnover Ratio (TTM) 0.01 0.01 0.01 0.06 0.14
TRDA's Total Ranking # 3855 # 4003 # 3187 # 3144 # 2728
Seq. Asset Change -10.71 % -10.92 % -11.09 % -8.6 % -8 %
Seq. Revenue Change 0.78 % 2.63 % -32.64 % -19.52 % -17.23 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 194
Healthcare Sector # 551
Overall Market # 3855

Asset Turnover Ratio Statistics
High Average Low
0.47 0.23 0.01
(Jun 30 2024)   (Jun 30 2026)




TRDA Company Profile • Back to TRDA Efficiency Comparisons • Compare TRDA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Metagenomi Therapeutics Inc   0.04 $ 7.086  Millions$ 187.286  Millions
Aclaris Therapeutics Inc   0.03 $ 6.401  Millions$ 188.758  Millions
Ideaya Biosciences Inc   0.03 $ 36.535  Millions$ 1,166.348  Millions
Dbv Technologies S a   0.02 $ 3.844  Millions$ 234.675  Millions
Anteris Technologies Global Corp   0.01 $ 2.332  Millions$ 227.598  Millions
Crispr Therapeutics Ag  0.01 $ 25.172  Millions$ 2,549.561  Millions
Upstream Bio Inc   0.01 $ 2.870  Millions$ 299.747  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.